News
GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.
For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.
Discover the critical connection between diabetes and heart disease, learn how to manage risks, and find out what preventive ...
India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...
C, the 'bad cholesterol', is a crucial factor in heart disease. Learn from experts how reducing LDL-C can save lives, ...
Guidelines for pregnancy care in individuals with preexisting diabetes mellitus include stopping GLP-1 RA use and avoiding metformin.
SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.
Researchers have found in a new research that SGLT2 inhibitors may provide dual benefits in treating both diabetes and fatty ...
Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results